Trial intelligence / Profile preview

Effects of different induction methods on hiccups in gynecological day surgery under general anesthesia with remimazolam

ChiCTR2300077521Phase 4Not yet recruiting

Sponsor
Weifang People's Hospital
Start
Nov 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of remimazolam (2 arms), sponsored by Weifang People's Hospital. Primary endpoint: Incidence of hiccup. Planned start Nov 2023; status: not yet recruiting.

02

Drugs

remimazolam

Beyond the preview

Go deeper on ChiCTR2300077521.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300077521.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call